Product Application
Immune cells
Potential Therapeutic Targets in Tumor Treatment - Siglec Family Proteins
Siglec, an acronym for Sialic acid-binding immunoglobulin-like lectins, represents a family of receptors that recognize sialylated glycans. The Siglec protein family is predominantly expressed on the surface of immune cells and is characterized by an immunoglobulin-like domain capable of binding sialic acids. These proteins play critical roles in mediating cell-cell interactions, as well as host-pathogen and host-tissue interactions, during processes such as infection and immune regulation.
View details
- Sigelc
- Immune cells
- tumor therapy
- 1












